-
Avoid These Eight Costly Biospecimen Procurement Mistakes
Bio-IT World Contributed Commentary | Every day counts when it comes to saving lives and generating revenue, especially when you’re trying to bring a drug, treatment, or diagnostic tool to market. Unfortunately, these processes often take a lot longer and cost a lot more than initially expected.
Jan 10, 2020
-
Top 10 Stories of 2019: National Genomic Data Initiatives, AI’s Impact in Drug Development, And More
Bio-IT World | As we head into 2020, we at Bio-IT World would like to take a moment and reflect on the groundbreaking achievements from this past year. In that spirit, here are the top 10 stories of 2019, ranked in order of popularity.
Jan 9, 2020
-
How To Improve Biopharmaceutical Research Data Utilization?
Bio-IT World Contributed Commentary | Many enterprise network security people intuitively put everything behind a firewall—even though it has been well-established that firewalls are big hindrance to high-speed data flows. There are a few reasons of poor data mobility and thus low utilization.
Jan 8, 2020
-
Follow the Money: New Life Sciences Investment Firm, Funding for Deep Genomics, Verantos, TwinStrand Biosciences, More
Bio-IT World Perceptive Advisors launches a new venture capital fund for early-stage life sciences companies. Deep Genomics closes its series B round to fund its AI-powered drug discovery platform. Several molecular diagnostics companies receive funding to advance PCR platforms and companion diagnostics. TwinStrand Biosciences closes a Series A fund to create a new genomic sequencing technology, and more.
Jan 7, 2020
-
Heart-In-A-Jar Platform Humanizing Preclinical Research
Bio-IT World | Stem cell biotech company Novoheart has been bioengineering miniature human hearts as a platform for drug discovery and development for several to pharmaceutical firms, notably for human conditions without a good animal model for preclinical testing. Novoheart’s thumb-sized human “heart-in-a-jar” models can both contract and eject blood-like fluid, making it possible to measure how well the heart is pumping.
Jan 6, 2020
-
Keeping It Real: Challenges And Benefits Of Integrating AI And Machine Learning Into Pharma R&D
Bio-IT World Contributed Commentary | Productivity in the pharmaceutical industry is rapidly declining. This crisis has created a need to re-think the way clinical trials are conceived, designed and conducted. As such, artificial intelligence is poised to transform the industry.
Jan 3, 2020
-
Illumina, PacBio Terminate Merger Agreement
Bio-IT World | Illumina and Pacific Biosciences of California today announced that they have mutually agreed to terminate their merger agreement. In accordance with the merger agreement, Illumina will pay Pacific Biosciences a termination fee of $98 million.
Jan 2, 2020
-
2020 Bio-IT Predictions: Digital Transformation Creates Opportunity and Obstacles
Bio-IT World Contributed Commentary | They say change is good, but it’s best if you have the ability to adapt. That’s certainly the case in the IT space, where digital transformation continues to drive rapid advancement across virtually every industry, and certainly in the life sciences. Here are some predictions and potential challenges to consider heading into next year.
Jan 2, 2020


